Newswise — February 5, 2015 – In patients who don't resume normal urination after surgery, a simple ultrasound test can accurately diagnose the common problem of postoperative urinary retention (POUR), reports a study in Anesthesia & Analgesia.
Using ultrasound to measure bladder diameter provides a quick and inexpensive test for POUR, according to the new research by Dr Aurélien Daurat and colleagues of Lapeyronie University Hospital, Montpelier, France. The researchers believe their simplified approach may obviate the need for costly automated devices for measuring bladder volume.
Quick Ultrasound Measure of Bladder Diameter…Dr Daurat and coauthors evaluated their simplified approach to ultrasound bladder measurement in 100 patients who were considered at risk of POUR because they were unable to void (urinate) after orthopedic surgery. Postoperative urinary retention is a common side effect after surgery and general anesthesia. If the bladder isn't emptied, POUR can prolong the patient's hospital stay and lead to potentially serious complications.
In the recovery room, all patients underwent a single ultrasound measurement of bladder diameter in the transverse dimension (from side to side). These measures were obtained by nurses using a pocket-sized portable ultrasound device.
All 100 patients then underwent measurement of bladder volume using a special automated device. About half of the patients underwent placement of a catheter to drain the bladder, which allowed measurement of the actual volume of urine. The results were compared to evaluate the ultrasound's ability test to diagnose POUR—defined as an automated measurement of 600 milliliters and/or the need for catheter placement.
…Can Accurately Diagnose Common Postoperative ProblemThe average bladder diameter was about 11 centimeters (cm) in patients with POUR, compared with 8 to 9 cm in those without POUR. The ultrasound-measured diameter was strongly correlated with the automated bladder volume measurement or the actual urine volume.
Ultrasound bladder measurement proved to be an accurate diagnostic test for POUR. If the bladder diameter was 9.7 cm or less, the patient could be safely discharged. If the diameter was larger than 10.7 cm, POUR might be present and catheter placement should be considered. The ultrasound test would be considered inconclusive only for patients in the "grey zone" between 9.7 and 10.7 cm.
Although POUR is a frequent and potentially serious problem, it can be challenging to recognize in the recovery room after surgery. The new study suggests that a single ultrasound bladder measurement provides a simplified yet accurate approach to making the diagnosis in patients who don't void after surgery.
The researchers note that the test can be efficiently performed by nurses using a widely available portable ultrasound device—an important advantage over approaches using more complex measurements or specialized equipment. "The findings of this study directly call into question the usefulness of expensive specific devices for assessing POUR in the postoperative period," Dr Daurat and coauthors conclude.
Article: “Diagnosis of Postoperative Urinary Retention Using a Simplified Ultrasound Bladder Measurement.” (DOI: 10.1213/ANE.0000000000000595)
About Anesthesia & AnalgesiaAnesthesia & Analgesia was founded in 1922 and was issued bi-monthly until 1980, when it became a monthly publication. A&A is the leading journal for anesthesia clinicians and researchers and includes more than 500 articles annually in all areas related to anesthesia and analgesia, such as cardiovascular anesthesiology, patient safety, anesthetic pharmacology, and pain management. The journal is published on behalf of the IARS by Lippincott Williams & Wilkins (LWW), a division of Wolters Kluwer Health.
About the IARSThe International Anesthesia Research Society is a nonpolitical, not-for-profit medical society founded in 1922 to advance and support scientific research and education related to anesthesia, and to improve patient care through basic research. The IARS contributes nearly $1 million annually to fund anesthesia research; provides a forum for anesthesiology leaders to share information and ideas; maintains a worldwide membership of more than 15,000 physicians, physician residents, and others with doctoral degrees, as well as health professionals in anesthesia related practice; sponsors the SmartTots initiative in partnership with the FDA; supports the resident education initiative OpenAnesthesia; and publishes two journals, Anesthesia & Analgesia and A&A Case Reports.
About Wolters Kluwer HealthWolters Kluwer Health is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Serving more than 150 countries worldwide, clinicians rely on Wolters Kluwer Health’s market leading information-enabled tools and software solutions throughout their professional careers from training to research to practice. Major brands include Health Language®, Lexicomp®, Lippincott Williams & Wilkins, Medicom®, Medknow, Ovid®, Pharmacy OneSource®, ProVation® Medical and UpToDate®.
Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company. Wolters Kluwer had 2013 annual revenues of €3.6 billion ($4.7 billion), employs approximately 19,000 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America.maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Alphen aan den Rijn, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
Follow our official Twitter handle: @WKHealth.
MEDIA CONTACTRegister for reporter access to contact details
Anesthesia & Analgesia